Atheroembolic renal disease: clinical findings of 11 cases.
Atheromatous embolism is a systemic disease resulting from cholesterol crystal embolization in many organs, including the kidneys. To characterize atheroembolic renal disease (AERD), we retrospectively evaluated 11 patients with acute renal failure after vascular surgery, vascular radiology investigations, and anticoagulation at Miyazaki Medical College from 1994 to 2001. The diagnosis of cholesterol atheromatous embolism was confirmed by tissue examination or clinical grounds. The patients were all elderly men (average age of 66.8 years) with a history of hypertension (55%), diabetes mellitus (45%), hyperlipidemia (45%), and coronary artery disease (18%). Seven patients had livedo reticularis, and 4 had blood eosinophilia. Clinically, 7 patients were managed conservatively and 5 of them improved, whereas 4 patients required dialysis and developed chronic renal failure or died. The serum creatinine levels of the improved patients were significantly lower (1.28+/-0.3 mg/dl, p < 0.005) than the non-improved ones (7.70+/-3.6). The number of eosinophils was significantly higher in the improved patients (576+/-295 /ml, p < 0.05) than in the non-improved ones (208+/-206). However, no significant difference was observed in the levels of serum cholesterol and C-reactive protein among these patients. Since the population at risk for AERD is growing, we should recognize this disease as a cause of acute renal failure.
Hara
Seiichiro
S
First Department of Internal Medicine, Miyazaki Medical College, Kiyotake, Miyazaki, Japan. shara@post1.miyazaki-med.ac.jp
Asada
Yujiro
Y
Fujimoto
Shouichi
S
Marutsuka
Kousuke
K
Hatakeyama
Kinta
K
Sumiyoshi
Akinobu
A
Eto
Tanenao
T
D058186:Acute Kidney Injury / Q000209:etiology* / Q000473:pathology* / Q000628:therapy; D000368:Aged; D001011:Aorta / Q000473:pathology; D017700:Embolism, Cholesterol / Q000150:complications* / Q000473:pathology* / Q000628:therapy; D004802:Eosinophilia / Q000150:complications / Q000473:pathology / Q000628:therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D016896:Treatment Outcome